My Cart

Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag, active dimer, low endotoxin (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
CD8-H52H3-100ug
$360.00
CD8-H52H3-1mg
$2495.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Synonym

    CD28, Tp44

  • Source

    Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag (CD8-H52H3) is expressed from human 293 cells (HEK293). It contains AA Asn 19 - Pro 152 (Accession # P10747-1). In the region Asn 19 - Pro 152, the AA sequence of Human, Cynomolgus and Rhesus macaque CD28 are homologus.

    Predicted N-terminus: Asn 19

    Request for sequence

  • Molecular Characterization

    CD28 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 20.4 kDa. The protein migrates as 38-45 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    CD28 SDS-PAGE

    Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    CD28 SEC-MALS

    The purity of Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag (Cat. No. CD8-H52H3) is more than 95% and the molecular weight of this protein is around 65-75 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     CD28 ELISA

    Immobilized Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag (Cat. No. CD8-H52H3) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) with a linear range of 0.01-1 ng/mL (QC tested).

    Protocol
  • Bioactivity-BLI

     CD28 BLI

    Loaded Human B7-1, Fc Tag (Cat. No. B71-H5259) on Protein A Biosensor, can bind Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag (Cat. No. CD8-H52H3) with an affinity constant of 4.5 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.

Recent Advances

 
Drug Development Progress
  • English Name:

    T-cell-specific surface glycoprotein CD28

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    31 Details

  • Highest Development Stage:

    Phase 2 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland